ASPN

Aspen Aerogels, Inc. (ASPN) Scenario Analysis Analysis (2026)

Invetso Score: 5/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Base Case

ASPN remains a turnaround-style setup with negative TTM earnings and margins, but liquidity is adequate with a current ratio of 2.52 and cash ratio of 1.54.

Valuation is not demanding on sales at 2.40x P/S and 2.27x EV/S, though profitability remains weak with TTM net margin of -62.4% and EBITDA margin of -36.9%.

Cash generation is mixed: operating cash flow is positive, but free cash flow conversion is uneven and FCF yield is only 7.7%.

Bull Case

If ASPN sustains operating cash flow and improves margins, the current balance sheet provides room to execute without immediate liquidity pressure.

Return on invested capital is positive at 0.60, suggesting the business can create value if profitability normalizes.

A lower valuation multiple could support upside if revenue growth and margin recovery continue.

Bear Case

Persistent negative earnings, ROE of -53.3%, and EBIT margin of -59.4% indicate the turnaround is not yet proven.

The cash conversion cycle of 85.7 days and elevated SG&A at 41.4% of revenue leave limited margin for error.

If operating performance weakens, the company could struggle to translate revenue into durable free cash flow despite acceptable near-term liquidity.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Aspen Aerogels, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →